Desafios da implementação do exame DNA-HPV no rastreamento do câncer do colo do útero na atenção primária à saúde e o papel do biomédico: revisão de literatura
This article analyzes the implementation of human papillomavirus DNA testing (HPV DNA test) as the primary screening method for cervical cancer in primary care, its advances and challenges, and how the literature addresses the role of the biomedical scientist. It is a narrative review of 17 publications from 2021 to 2026, purposively selected: 11 reviews, five studies with epidemiological or health service data, and one announcement from the Brazilian Ministry of Health. The reviews describe the test as more sensitive than cytology (90% to 95% versus 50% to 70%), with a five-year interval after a negative result and self-sampling, but with lower specificity and higher cost, which requires triage of positive cases. A national estimate points to a shortfall of biopsies and excisions in all states and of colposcopies in almost all. Training and infrastructure are cited as requirements, but no publication on screening mentions the biomedical scientist. It is concluded that the literature analyzed describes the HPV DNA test as an advance whose implementation requires a diagnostic confirmation and treatment network, staff training and equitable access, and that the role of the biomedical scientist, only inferred from the laboratory steps of the test, was not addressed in this set.
Authors
- Rosinaide Valquiria Lenzi
- Camila Vitoria Mariano Vigilato
- Gabriel da Costa Santos
- Ilecari de Fatima Leonel da Cruz Gimenez
- Iris Beatriz Frez
Institutions
- Faculdades Integradas Aparício Carvalho (BR)
Publication Details
- Journal
- Revista fisio&terapia.
- Published
- 2026-11-20
- DOI
- https://doi.org/10.69849/wrc7c621
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00